Holdings Bhd reported a 25% year-on-year revenue growth in the first quarter of 2025, reflecting the success of its ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business ...

But at least some employees have reported problems with its execution. “Met all the ‘drop dead’ deadlines ... campaign to ...

On December 17, 2024, the Company received recognition from the prestigious 2024 "Annual Seven-Star Awards for Outstanding Contributions in Food Safety & Public Health" for the fourth year. This honor ...

Continued execution across Ampligen ® (rintatolimod) clinical development programs in areas with critical unmet needs, ...

The expansion of global capability centres (GCCs) in India is driving demand for Grade-A office spaces, with GCCs ...

In FY2024 alone, India added a record 24.5 GW of solar capacity, more than double the previous year's installations. The report also highlights a shift toward self-reliance, with solar module ...

Lembaga Tabung Haji (TH) today announced a profit distribution of 3.25 percent after zakat for the 2024 financial year, the highest rate in seven years since 2018. Minister in the Prime Minister ...

Q4 2024 revenues were $10.3 million, up 47% from Q4 2023. This was an all-time quarterly record for the Company. Full year 2024 revenues were $32.6 million, up 60% from full year 2023 revenues ...

Advertisement "The execution tonight took place without incident," he said. The method of execution was not mentioned, though the Death Penalty Information Center states that Florida's method of ...

EDEN PRAIRIE, Minn., March 21, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products ...